Pooled analysis of two randomized phase III trials (PlanB/SuccessC) comparing six cycles of docetaxel and cyclophosphamide to sequential anthracycline taxane chemotherapy in patients with intermediate and high risk HER2-negative early breast cancer (n = 5,923) - Janni, W; Nitz, U; Rack, B K (J Clin Oncol, 2018)
. doi:510.1200/JCO.2018.1236.1215_suppl.1522